Introduction
Lennox-Gastaut syndrome (LGS) is a relatively uncommon epileptic encephalopathy.
LGS is characterized by intractable, multiple seizure types and an interictal electroencephalogram (EEG) showing bursts of slow spike-and-wave complexes (SSW), generalized paroxysmal fast activity (GPFA), and a slow background. All patients have lifelong epilepsy. 1 It has been thought that mental retardation (MR) is seen in all patients and it was suggested that it should be a part of the diagnostic criteria. However, there are reports on patients with LGS and without MR. 2 Onset of LGS is usually before the age of 8 years. Occurrence rates peak between 3 and 5 years of age, although late-onset cases have been reported. 3 LGS, which accounts for approximately 1-10% of all childhood epilepsies, is notoriously resistant to medical and even surgical treatments. [1] [2] [3] When these patients become adults, most continue to experience seizures as well as cognitive, psychiatric, and behavioral problems. 4 Therefore, it is not surprising that the disorder has a devastating impact on patients' quality of life and imposes a considerable burden on their families. 5 Misdiagnosis and consequently mistreatment of this syndrome is common. 1 In the current study, we tried to determine the clinical and electroencephalographic manifestations of patients with LGS in south Iran.
Methods and material
In this cross-sectional retrospective chart review study, all patients with a clinical diagnosis of LGS were recruited at the outpatient epilepsy clinic at Shiraz University of Medical Sciences, which is the only epilepsy clinic in south Iran, from September 2008 through May 2012. The diagnosis of LGS was made based on the clinical and electroencephalographic grounds 1 and all patients had to be under the care of the epileptologist at our institution. Out-patient EEG (either awake or sleep) was performed in all patients at the time of referral. Study time for EEG was 10 min and we performed intermittent photic stimulation in all patients. Hyperventilation was typically performed in children above five We studied the demographic, clinical, EEG and imaging findings. Age, gender, age at seizure onset, seizure type(s), epilepsy risk factors (including history of pregnancy complications or significant head trauma, positive family history of epilepsy and parental consanguinity), EEG and imaging findings of all patients were registered routinely. Demographic variables and relevant clinical variables were summarized descriptively to characterize the study population. This study was conducted with approval of the Shiraz University of Medical Sciences Review Board.
Results
During the study period, 2500 patients with epilepsy were registered at our epilepsy clinic. One-hundred and thirty-five patients (5.4%) were diagnosed as having LGS. Age of onset (mean AE standard deviation) was 3.2 AE 3.8 years. Minimum age of onset was the neonatal period and maximum age was 17 years (Fig. 1 ). In 14 (10.4%) patients, age of onset was above 8 years. Eightythree patients were male (61.5%) and 52 (38.5%) were female. The age of the patients at referral was 12.4 AE 8.8 years. The minimum age at referral was seven months and the maximum age was 43 years.
Fifty-eight patients (43%) reported having two seizure types and 77 (57%) had three or more seizure types. Tonic seizures were reported in 90 (66.7%); generalized tonic-clonic seizures in 83 patients (61.5%); myoclonic seizures in 79 (58.5%); atypical absences in 66 (49%); atonic seizures in 27 (20%); astatic (drop attacks) in 14 (10%); and complex partial seizures in 12 (9%). Thirty-five (26%) patients had history of episodes of status epilepticus.
Epilepsy risk factors were reported to be as follows: perinatal complications in 34 patients (25%) (including, hypoxic-ischemic insults in 28 and sepsis, low-birth-weight and hyperbilirubinemia in others); CNS infections in 5 (3.7%); family history of epilepsy in 33 (24.4%); parental consanguinity in 67 (49.6%); and history of significant head trauma in one patient.
Three patients were not mentally retarded and the rest had mild to severe cognitive impairment. One patient was a university student in electrical engineering at a local university, one had high school diploma and another one finished his 9th grade. Many patients had medical or neurological comorbidities. These included: cerebral palsy in 45 (33%); attention-deficit hyperactivity disorder in 11 (8%); hypothyroidism 4 (3%); congenital heart disease in 3 (2%); cancer in 2 (1.5%); and tuberous sclerosis, diabetes mellitus, hypopituitarism, renal failure, and hearing loss, each in one patient.
We requested EEG for all patients at the time of referral (Table 1 ). Brain imaging studies were done in 102 patients; 33 patients could not afford these tests. The results are summarized in Table 2 . Blood tests were not performed in the majority of patients (81 patients; 60%). When it was performed, it was not conclusive in most cases. Blood tests were normal in 48 patients (35.6%), but showed lactic acidosis in two, anemia and vitamin B-12 deficiency in one, hypothyroidism in one, hypercholesterolemia in one, and hypocalcemia in another patient.
Discussion
Lennox-Gastaut syndrome (LGS) is a relatively uncommon epileptic encephalopathy. LGS is often characterized by a triad of multiple seizure types, a specific interictal EEG showing bursts of slow spike-wave complexes and/or generalized paroxysmal fast activity, and mental retardation In the current study, 5.4% of all patients with epilepsy (children and adults) had LGS, which is slightly higher than the rates reported in some previous studies. 1, 6, 7 The prevalence has been estimated at 1-2% of all patients with epilepsy, although figures as high as 10% have been reported. 7 In a previous study from the USA, LGS accounted for 4% of all childhood epilepsies. 6 The probable reason for this discrepancy will be discussed later. Clinical manifestations of LGS are more or less similar in various studies. The sex ratio (male to female) and age of onset of LGS in our study were similar to previous reports. 1, 6, 8 Males outnumber females in LGS (male to female ratio in our study = 1.6:1). Age of onset is often below eight years; however in about 10% of our patients the syndrome started after 8 years of age. Late-onset LGS has been reported in the literature before. In a previous study, 15% of the patients with LGS had late-onset disease. 8 It is advised to consider and investigate for genetic disorders, particularly chromosomal abnormalities, in patients with late-onset LGS.
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The clinical hallmark of LGS is having multiple seizure types. In our study, two-fifths of the patients had two seizure types and three-fifths had three or more seizure types. Tonic seizure was the most common seizure type, followed by generalized tonic-clonic, myoclonic and atypical absence seizures. This is very similar to previous reports. 1, 8 However, to correctly diagnose the seizure types and consequently the syndrome itself needs a standardized approach, particularly with regards to taking a detailed clinical history. The routine use of a standard proforma minimizes the risk of missing clinical findings, including seizure types, and most of the time leads to a correct diagnosis. 12 An incorrect diagnosis may indeed have many negative consequences; one is taking suboptimal antiepileptic drugs. Misinterpretation of tonic and myoclonic seizures as complex partial seizures and subsequently, mistreatment of the syndrome has been reported in a previous study. 13 Mental retardation has been considered as a criterion of the classic triad seen in patients with LGS; however, some patients have normal or near-normal cognitive profile.
14 There are authors who have chosen not to include mental retardation as a requirement for defining LGS in their studies. 8 In our study, 2.2% of patients had normal cognitive function and achieved some education. In a previous study from the same region (i.e., the Middle East), 4% of the patients did not have mental retardation. 15 Epilepsy risk factors, particularly perinatal complications, and also comorbid neurological and medical conditions observed in our patients were more or less similar to previous studies. 6, 8 However, rate of parental consanguinity (about 50%) was high in our study. Similarly, the rate of family history of epilepsy (24%) observed among our patients was high. In a previous Western study, the latest figure was only 13%, 8 however, in a previous report from the Middle East, positive consanguinity was observed in 30% and positive family history of epilepsy was found in 22% of the patients. 15 High consanguinity rate was previously reported in patients with epilepsy from the same region (Shiraz, Iran). 16 In that study, it was observed that the percentage of consanguinity in parents of the patients with epilepsy was significantly higher compared to a sample of the general population (Odds Ratio = 2.6; 95%-Confidence Interval: 1.929-3.536; P < 0.0001). This high rate of familial marriage might result in more prevalent genetic disorders (e.g., neuronal migrational disorders, metabolic disorders such as mitochondrial respiratory chain defects, etc.), which could present as LGS, clinically. 17 Maybe, one reason for observing high rate of family history of epilepsy among our patients (24%) compared to a previous study (13%) 8 is this high rate of parental consanguinity. Likewise, it is probable that higher percentage of LGS among all epilepsies observed in our study compared to some previous reports 7 is related to the high rate of familial marriage in our region, at least to some extent. This finding needs further exploration in future investigations. The hallmark electroencephalographic feature in LGS is slow (<2.5 Hz) spike-wave bursts with abnormal background activity. 1 Similar results were observed in our study (Table 1) . However, not all patients with LGS have slow spike-waves (SSW) in their EEGs. In our study, about 13% of patients did not have SSW. Bursts of generalized paroxysmal fast activity (10-20 Hz) (GPFA), particularly during sleep, also define the EEG profile of the LGS. 1 LGS are present and EEG shows background abnormality and a diffuse (e.g., polyspikes) or multifocal epileptiform abnormality and you cannot make a better syndromic diagnosis, we suggest considering LGS, despite not seeing either SSW or GPFA in EEG. The EEG background probably is never normal in LGS and shows a diffuse slowing and absent normal rhythms. 1 In our study, three patients had normal background activity in their EEG. This was probably due to technical problems, most importantly short recording time, in our EEG lab. Brain MRI is probably the most important diagnostic tool to help identify the etiology of LGS. The spectrum of brain MRI abnormalities in our patients with LGS was similar to a previous study. 18 However, in our study, brain imaging was normal in more than half of the patients that is much higher than the rate observed in that previous study (22%). 18 In another study from the Middle East, in 36% of the patients who had brain MRI, the results were normal and in most of those with abnormal MRI, brain atrophy was reported. 15 These discrepancies are probably related to technical problems (e.g., most of our pediatric patients had performed 0.5 T MRI). Modern 3 T MRI scanners and sequences can be used to identify subtle abnormalities in patients with refractory epilepsy and previously unremarkable or inconclusive brain MRI scans. 19 Other laboratory studies (which were very limited) were often normal or non-specific in our study; however in a minority of patients metabolic disorders could be detected. It has been advised that patients with no identifiable etiology or those with normal or non-specific brain imaging should receive evaluations for inborn errors of metabolism. 7 
Conclusion
Lennox-Gastaut syndrome is an uncommon epileptic encephalopathy characterized by multiple seizure types, a specific electroencephalographic pattern (slow spike-waves or generalized paroxysmal fast activity) and psychomotor retardation, beginning in childhood. However, variants of this classical triad including atypical EEG findings, normal psychomotor function, and lateonset disease could be seen in some patients. These atypical findings in a patient with typical history for LGS should not deter from the correct diagnosis. The mainstay for making a correct syndromic diagnosis is a detailed clinical history.
Limitations of the study
This was a clinic-based series and may not represent the full spectrum of patients with Lennox-Gastaut syndrome; because the mildest disease varieties may not be referred to a university clinic and therefore, the possibility of selection bias remains in place.
Another limitation of our study is that, in some patients we did not record sleep EEG and EEG time in the out-patient setting was too short to record deep sleep in most cases. Besides, we did not have access to high quality imaging studies (e.g., 3 T MRI) and sophisticated genetic and metabolic studies. As a matter of fact, in a large number of the patients even a simple imaging study such as CT scan was not available; therefore, we could not identify the etiology with certainty and we did not try to enter into the etiologic classification of LGS in this paper.
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